- Home
- SSKN vs QNTM Comparison
SSKN vs QNTM Comparison
Compare SSKN & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- QNTM
- Stock Information
- Founded
- SSKN 1989
- QNTM 1998
- Country
- SSKN United States
- QNTM Canada
- Employees
- SSKN N/A
- QNTM N/A
- Industry
- SSKN Medical/Dental Instruments
- QNTM
- Sector
- SSKN Health Care
- QNTM
- Exchange
- SSKN Nasdaq
- QNTM NYSE
- Market Cap
- SSKN 10.6M
- QNTM 8.7M
- IPO Year
- SSKN 2005
- QNTM N/A
- Fundamental
- Price
- SSKN $2.62
- QNTM $7.86
- Analyst Decision
- SSKN Strong Buy
- QNTM
- Analyst Count
- SSKN 1
- QNTM 0
- Target Price
- SSKN $6.00
- QNTM N/A
- AVG Volume (30 Days)
- SSKN 4.0K
- QNTM 1.5M
- Earning Date
- SSKN 03-27-2025
- QNTM 05-13-2025
- Dividend Yield
- SSKN N/A
- QNTM N/A
- EPS Growth
- SSKN N/A
- QNTM N/A
- EPS
- SSKN N/A
- QNTM N/A
- Revenue
- SSKN $33,562,000.00
- QNTM N/A
- Revenue This Year
- SSKN $0.79
- QNTM N/A
- Revenue Next Year
- SSKN $8.17
- QNTM N/A
- P/E Ratio
- SSKN N/A
- QNTM N/A
- Revenue Growth
- SSKN 0.61
- QNTM N/A
- 52 Week Low
- SSKN $2.51
- QNTM $2.70
- 52 Week High
- SSKN $5.90
- QNTM $44.20
- Technical
- Relative Strength Index (RSI)
- SSKN 46.56
- QNTM 58.66
- Support Level
- SSKN $2.55
- QNTM $6.45
- Resistance Level
- SSKN $2.72
- QNTM $12.45
- Average True Range (ATR)
- SSKN 0.14
- QNTM 1.68
- MACD
- SSKN 0.00
- QNTM 0.23
- Stochastic Oscillator
- SSKN 40.74
- QNTM 35.97
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.